Zantac Sales Halted by Walgreens and CVS Over Carcinogen Fears
The pharmacy chains pulled the heartburn medication from shelves after the Food and Drug Administration warned that it had detected low levels of a cancer-causing chemical in samples of the drug.
View original article
Contributor:
